Inhibikase Therapeutics IKT
$ 3.15
-1.72%
Quarterly report 2024-Q3
added 11-14-2024
Inhibikase Therapeutics EV/EBITDA Ratio 2011-2024 | IKT
Annual EV/EBITDA Ratio Inhibikase Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
1.25 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
1.25 | 1.25 | 1.25 |